Ambassador King hosted an event marking Vertex Pharmaceuticals office opening in the Czech Republic. “Although, sometimes we tend to focus more on large investments, I believe that even smaller companies can make a huge difference in the market, especially in the healthcare arena,” noted Ambassador King.
Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. The company discovered and developed the first medicines that target mutated CFTR protein – the underlying cause of cystic fibrosis (CF). It was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.